Additionally, higher EIF4A3 protein levels were observed in HCC samples from the CPTAC cohort compared to NTAT (Figure 2G), associated with lower survival and higher recurrence, and correlated with the number of tumours, alpha‐fetoprotein levels and tumour size (Figure 2H). The gene discussed is EIF4A3; the disease is hepatocellular carcinoma.